Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Jan 29, 2017 | $65.8B |
| FY2018, ended Jan 28, 2018 | $147B |
| FY2019, ended Jan 27, 2019 | $97.1B |
| FY2020, ended Jan 26, 2020 | $153B |
| FY2021, ended Jan 31, 2021 | $322B |
| FY2022, ended Jan 30, 2022 | $573B |
| FY2023, ended Jan 29, 2023 | $503B |
| FY2024, ended Jan 28, 2024 | $1.53T |
| FY2025, ended Jan 26, 2025 | $3.48T |
| FY2026, ended Jan 25, 2026 | $4.56T |
| Trailing 12 months to Jul 26, 2026 (through Q2 FY2027) | $4.98T |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Jan 29, 2017 | $6.91B |
| FY2018, ended Jan 28, 2018 | $9.71B |
| FY2019, ended Jan 27, 2019 | $11.7B |
| FY2020, ended Jan 26, 2020 | $10.9B |
| FY2021, ended Jan 31, 2021 | $16.7B |
| FY2022, ended Jan 30, 2022 | $26.9B |
| FY2023, ended Jan 29, 2023 | $27.0B |
| FY2024, ended Jan 28, 2024 | $60.9B |
| FY2025, ended Jan 26, 2025 | $130B |
| FY2026, ended Jan 25, 2026 | $216B |
| Trailing 12 months to Jul 26, 2026 (through Q2 FY2027) | $303B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Jan 29, 2017 | $1.67B | — |
| FY2018, ended Jan 28, 2018 | $3.05B | — |
| FY2019, ended Jan 27, 2019 | $4.14B | — |
| FY2020, ended Jan 26, 2020 | $2.80B | — |
| FY2021, ended Jan 31, 2021 | $4.33B | — |
| FY2022, ended Jan 30, 2022 | $9.75B | $8.13B |
| FY2023, ended Jan 29, 2023 | $4.37B | $3.81B |
| FY2024, ended Jan 28, 2024 | $29.8B | $27.0B |
| FY2025, ended Jan 26, 2025 | $72.9B | $60.9B |
| FY2026, ended Jan 25, 2026 | $120B | $96.7B |
| Trailing 12 months to Jul 26, 2026 (through Q2 FY2027) | $193B | $127B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Jan 29, 2017 | $1.77B |
| FY2018, ended Jan 28, 2018 | $4.00B |
| FY2019, ended Jan 27, 2019 | $782M |
| FY2020, ended Jan 26, 2020 | $10.9B |
| FY2021, ended Jan 31, 2021 | $847M |
| FY2022, ended Jan 30, 2022 | $1.99B |
| FY2023, ended Jan 29, 2023 | $3.39B |
| FY2024, ended Jan 28, 2024 | $7.28B |
| FY2025, ended Jan 26, 2025 | $8.59B |
| FY2026, ended Jan 25, 2026 | $10.6B |
| Trailing 12 months to Jul 26, 2026 (through Q2 FY2027) | $22.4B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Jan 29, 2017 | $1.98B |
| FY2018, ended Jan 28, 2018 | $1.99B |
| FY2019, ended Jan 27, 2019 | $1.99B |
| FY2020, ended Jan 26, 2020 | $1.99B |
| FY2021, ended Jan 31, 2021 | $6.96B |
| FY2022, ended Jan 30, 2022 | $10.9B |
| FY2023, ended Jan 29, 2023 | $11.0B |
| FY2024, ended Jan 28, 2024 | $9.71B |
| FY2025, ended Jan 26, 2025 | $8.46B |
| FY2026, ended Jan 25, 2026 | $8.47B |
| Trailing 12 months to Jul 26, 2026 (through Q2 FY2027) | $33.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 2.4% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Jan 29, 2017 | 23.5B |
| FY2018, ended Jan 28, 2018 | 24.2B |
| FY2019, ended Jan 27, 2019 | 24.2B |
| FY2020, ended Jan 26, 2020 | 24.5B |
| FY2021, ended Jan 31, 2021 | 24.8B |
| FY2022, ended Jan 30, 2022 | 25.1B |
| FY2023, ended Jan 29, 2023 | 24.7B |
| FY2024, ended Jan 28, 2024 | 25.0B |
| FY2025, ended Jan 26, 2025 | 24.4B |
| FY2026, ended Jan 25, 2026 | 24.3B |
| Trailing 12 months to Jul 26, 2026 (through Q2 FY2027) | 24.1B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2017, ended Jan 29, 2017 | $739M | $247M |
| FY2018, ended Jan 28, 2018 | $909M | $391M |
| FY2019, ended Jan 27, 2019 | $1.58B | $557M |
| FY2020, ended Jan 26, 2020 | $0 | $844M |
| FY2021, ended Jan 31, 2021 | $0 | $1.40B |
| FY2022, ended Jan 30, 2022 | $0 | $2.00B |
| FY2023, ended Jan 29, 2023 | $10.0B | $2.71B |
| FY2024, ended Jan 28, 2024 | $9.53B | $3.55B |
| FY2025, ended Jan 26, 2025 | $33.7B | $4.74B |
| FY2026, ended Jan 25, 2026 | $40.1B | $6.39B |
| Trailing 12 months to Jul 26, 2026 (through Q2 FY2027) | $55.3B | $7.24B |
Valuation
At current price- Market Cap
- $5.25T
- P/E
- 27.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 17.3×
- Price / Book
- 22.9×
- EV / EBITDA
- 26.2×
Growth
Trailing 12 months- Revenue (TTM)
- $303B
- Revenue Growth YoY
- 83.4%
- Revenue CAGR 3Y
- 100%
- Revenue CAGR 5Y
- 66.9%
- EPS Growth YoY
- 125%
- Net Income Growth YoY
- 123%
Profitability
Trailing 12 months- Gross Margin
- 74.7%
- Operating Margin
- 65.2%
- Net Margin
- 63.7%
- FCF Margin
- 41.9%
- Return on Equity
- 117%
Earnings
Trailing 12 months- Net Income
- $193B
- EPS (diluted)
- $7.91
- EBITDA
- $201B
- Operating Income
- $198B
Balance Sheet
As of Jul 26, 2026- Cash and cash equivalents
- $22.4B
- Total Debt
- $33.4B
- Net Debt
- $10.9B
- Total Assets
- $320B
- Total Liabilities
- $91.3B
- Shareholders' Equity
- $229B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $134B
- Capital Expenditure
- $7.35B
- Free Cash Flow
- $127B
Dividends and risk
Last 12 months- Dividend Yield
- 0.2%
- Dividend / Share
- $0.52
- Beta (5Y)
- 2.21
Every ratio is calculated from the company’s reported figures.